Showing results (381-390 of 6,951) with videos related to
Sort By:
Pageof 696
Journal of Clinical Pharmacology|May 16, 2009
Lack of pharmacokinetic drug interactions following concomitant administration of telavancin with aztreonam or piperacillin/tazobactam in healthy participantsShekman L Wong, Fritz Sörgel, Martina Kinzig, et al.Journal of Clinical Pharmacology|September 29, 2009
Bioavailability of mycophenolate mofetil and enteric-coated mycophenolate sodium is differentially affected by pantoprazole in healthy volunteersKorbinian Rupprecht, Christoph Schmidt, Anne Raspé, et al.Journal of Clinical Pharmacology|October 1, 2009
Effect of the bile acid sequestrant colesevelam on the pharmacokinetics of pioglitazone, repaglinide, estrogen estradiol, norethindrone, levothyroxine, and glyburideKaren S Brown, Ingrid C Armstrong, Antonia Wang, et al.Journal of Clinical Pharmacology|September 25, 2009
Quantitative population pharmacokinetic analysis of pravastatin using an enterohepatic circulation model combined with pharmacogenomic Information on SLCO1B1 and ABCC2 polymorphismsTakafumi Ide, Tomohiro Sasaki, Kazuya Maeda, et al.Journal of Clinical Pharmacology|July 25, 2009
Lack of pharmacokinetic interactions between transdermal rotigotine and oral levodopa/carbidopaMarina Braun, Willi Cawello, Jens-Otto Andreas, et al.Journal of Clinical Pharmacology|July 25, 2009
Steady-state pharmacokinetics following application of a novel transdermal estradiol spray in healthy postmenopausal womenTerri L Morton, David J Gattermeir, Craig A Petersen, et al.Journal of Clinical Pharmacology|August 29, 2009
Single- and multiple-dose pharmacokinetics and dose proportionality of the psychotropic agent paliperidone extended releaseSandra Boom, Krishna Talluri, Luc Janssens, et al.Journal of Clinical Pharmacology|July 21, 2009
Population pharmacokinetics of golimumab, an anti-tumor necrosis factor-alpha human monoclonal antibody, in patients with psoriatic arthritisZhenhua Xu, Thuy Vu, Howard Lee, et al.Journal of Clinical Pharmacology|September 8, 2009
Is a thorough QTc study necessary? The role of modeling and simulation in evaluating the QTc prolongation potential of drugsShashank Rohatagi, Timothy J Carrothers, Jon Kuwabara-Wagg, et al.Journal of Clinical Pharmacology|February 1, 1990
Beta-adrenoceptor blockade and CNS-related subjective symptoms: a randomized, double-blind, placebo-controlled comparison of metoprolol CR/ZOK, atenolol and propranolol LA in healthy subjectsE Dimenäs, D Kerr, I MacdonaldPageof 696